Phlegmon laboratory findings

Phlegmon Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Phlegmon from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Phlegmon laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Phlegmon laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onPhlegmon laboratory findings
CDC on Phlegmon laboratory findings
Phlegmon laboratory findings in the news
Blogs on Phlegmon laboratory findings
Directions to Hospitals Treating Phlegmon
Risk calculators and risk factors for Phlegmon laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

On blood test, leucocytosis (up to 10-12x109/L), decrease or absence of eosinophils, shift of leucocyte formula to the left, and increased ESR (up to 35-40 mm/hr) may be present. Presence of bacteria in urine and increased urinary leucocyte counts may be observed on urinalysis.